APPLICATION OF ASTASANTINA OF MICROALGAE IN MACULAR DEGENERATION. MIDMAE (Q3214752): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||
| Property / budget | |||||||
23,383.25 Euro
| |||||||
| Property / budget: 23,383.25 Euro / rank | |||||||
Normal rank | |||||||
| Property / co-financing rate | |||||||
80.0 percent
| |||||||
| Property / co-financing rate: 80.0 percent / rank | |||||||
Normal rank | |||||||
| Property / EU contribution | |||||||
18,706.6 Euro
| |||||||
| Property / EU contribution: 18,706.6 Euro / rank | |||||||
Normal rank | |||||||
Revision as of 09:21, 21 October 2021
Project Q3214752 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | APPLICATION OF ASTASANTINA OF MICROALGAE IN MACULAR DEGENERATION. MIDMAE |
Project Q3214752 in Spain |
Statements
18,706.6 Euro
0 references
23,383.25 Euro
0 references
80.0 percent
0 references
7 October 2015
0 references
31 March 2017
0 references
NEOALGAE MICRO SEAWEED PRODUCTS
0 references
43°27'16.45"N, 5°51'2.30"W
0 references
33035
0 references
El proyecto MIDMAE ha estudiado la aplicación de la Astaxantina en relación con los problemas oculares._x000D_ La Astaxantina es un carotenoide liposoluble que se encuentra en la microalga Haematococcus pluvialis y es un antioxidante 10 veces más fuerte que el beta-caroteno y hasta 500 veces más fuerte que la vitamina E._x000D_ La Astaxantina neutraliza los radicales libres, combatiendo enfermedades relacionadas con la edad, como la Degeneración Macular Asociada a la Edad (DMAE), mediante la prevención de la proliferación de estas moléculas inestables. (Spanish)
0 references
The MIDMAE project has studied the application of Astaxanthin in relation to eye problems._x000D_ Astaxanthin is a liposoluble carotenoid found in the microalgae Haematococcus pluvialis and is an antioxidant that is 10 times stronger than beta-carotene and up to 500 times stronger than vitamin E._x000D_ Astaxanthin neutralises free radicals, fighting age-related diseases such as Age-Related Macular Degeneration (AMD), by preventing the proliferation of these unstable molecules. (English)
0 references
Llanera
0 references
Identifiers
IDE/2015/000810
0 references